Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2023-01-25
2023-10-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combined Effects of Plyometric and Endurance Training Among Female Hockey Players
NCT06509672
Effects of Short Duration Blood Flow Restriction Training on Musculoskeletal and Performance Outcomes
NCT06406907
Effects of Sprint Interval Training on Field Hockey Players.
NCT06502626
Comparison Between Blood Flow Resistance and Slow Motion Strength Training in Wrestlers
NCT06027138
Effects of Lower Limb Concentric Versus Eccentric Dynamic Resistance Training on Agility and Speed in Badminton Players
NCT06509607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Occlusion Training
Occlusion Training
In experimental sessions players will perform with occlusion training which is blood flow resistance training, 4 times a week for 4 weeks with 5 sets of 5 repetitions and then assessed pre-training and post-training values with assessment tools bench press, leg squat, leg power, maximum sprint time.This training will also improve and increase muscular strength as well as speed and physical performance in players.
General exercises without occlusion
General Exercises without occlusion training
General Exercises as bench press, squats , maximum sprint, leg power without occlusion training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General Exercises without occlusion training
General Exercises as bench press, squats , maximum sprint, leg power without occlusion training
Occlusion Training
In experimental sessions players will perform with occlusion training which is blood flow resistance training, 4 times a week for 4 weeks with 5 sets of 5 repetitions and then assessed pre-training and post-training values with assessment tools bench press, leg squat, leg power, maximum sprint time.This training will also improve and increase muscular strength as well as speed and physical performance in players.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Athletes with age group of 19-30 years of age.
* All players who had a minimum of two years of resistance training experience
Exclusion Criteria
* Players having history of prior surgery.
19 Years
30 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amna Shahid, t-DPT
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pakistan Sports Board
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/RCR&AHS/23/0403
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.